Tissue plasminogen activator reduces neurological damage after cerebral embolism - PubMed (original) (raw)

Tissue plasminogen activator reduces neurological damage after cerebral embolism

J A Zivin et al. Science. 1985.

Abstract

Intravenous administration of tissue plasminogen activator immediately after the injection of numerous small blood clots into the carotid circulation in rabbit embolic stroke model animals caused a significant reduction in neurological damage. In vitro studies indicate that tissue plasminogen activator produced substantial lysis of clots at concentrations comparable to those expected in vivo, suggesting that this may be the mechanism of action of this drug. Drug-induced hemorrhages were not demonstrable. Tissue plasminogen activator may be of value for the immediate treatment of embolic stroke.

PubMed Disclaimer

Similar articles

• Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke.
  Zivin JA, Lyden PD, DeGirolami U, Kochhar A, Mazzarella V, Hemenway CC, Johnston P. Zivin JA, et al. Arch Neurol. 1988 Apr;45(4):387-91. doi: 10.1001/archneur.1988.00520280033012. Arch Neurol. 1988. PMID: 3128254
• Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
  Lyden PD, Madden KP, Clark WM, Sasse KC, Zivin JA. Lyden PD, et al. Stroke. 1990 Nov;21(11):1589-93. doi: 10.1161/01.str.21.11.1589. Stroke. 1990. PMID: 2122552
• Evaluation of recombinant tissue plasminogen activator in embolic stroke.
  Chehrazi BB, Seibert JA, Kissel P, Hein L, Brock JM. Chehrazi BB, et al. Neurosurgery. 1989 Mar;24(3):355-60. doi: 10.1227/00006123-198903000-00008. Neurosurgery. 1989. PMID: 2494563
• Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
  Thomas GR, Thibodeaux H, Bennett WF, Refino CJ, Badillo JM, Errett CJ, Zivin JA. Thomas GR, et al. J Pharmacol Exp Ther. 1993 Jan;264(1):67-73. J Pharmacol Exp Ther. 1993. PMID: 8423552
• Thrombolytic therapy in experimental embolic stroke.
  Overgaard K. Overgaard K. Cerebrovasc Brain Metab Rev. 1994 Fall;6(3):257-86. Cerebrovasc Brain Metab Rev. 1994. PMID: 7811566 Review.

Cited by

• Preclinical Stroke Research and Translational Failure: A Bird's Eye View on Preventable Variables.
  Singh D, Wasan H, Reeta KH. Singh D, et al. Cell Mol Neurobiol. 2022 Oct;42(7):2003-2017. doi: 10.1007/s10571-021-01083-6. Epub 2021 Mar 30. Cell Mol Neurobiol. 2022. PMID: 33786698 Review.
• A surgical model of permanent and transient middle cerebral artery stroke in the sheep.
  Wells AJ, Vink R, Blumbergs PC, Brophy BP, Helps SC, Knox SJ, Turner RJ. Wells AJ, et al. PLoS One. 2012;7(7):e42157. doi: 10.1371/journal.pone.0042157. Epub 2012 Jul 27. PLoS One. 2012. PMID: 22848737 Free PMC article.
• A thromboembolic model for the efficacy and safety evaluation of combined mechanical and pharmacologic revascularization strategies.
  Gounis MJ, Nogueira RG, Mehra M, Chueh J, Wakhloo AK. Gounis MJ, et al. J Neurointerv Surg. 2013 May;5 Suppl 1(Suppl 1):i85-9. doi: 10.1136/neurintsurg-2012-010435. Epub 2012 Sep 8. J Neurointerv Surg. 2013. PMID: 22962414 Free PMC article.
• A concerted appeal for international cooperation in preclinical stroke research.
  Dirnagl U, Hakim A, Macleod M, Fisher M, Howells D, Alan SM, Steinberg G, Planas A, Boltze J, Savitz S, Iadecola C, Meairs S. Dirnagl U, et al. Stroke. 2013 Jun;44(6):1754-60. doi: 10.1161/STROKEAHA.113.000734. Epub 2013 Apr 18. Stroke. 2013. PMID: 23598526 Free PMC article. No abstract available.
• The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia.
  Penar PL, Greer CA. Penar PL, et al. Yale J Biol Med. 1987 May-Jun;60(3):233-43. Yale J Biol Med. 1987. PMID: 3111108 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database